OTC Medicines

Browse OTC Medicines Content

Providing coverage for clinically-validated, over-the-counter products capable of preventing complications or replacing higher cost prescriptions through flexible spending arrangements aligns with value-based models working to improve access and outcomes across populations.

Under a voluntary program which began in November 2007, manufacturers of OTC oral pediatric cough and cold medicines should take the following steps in the labeling, packaging, and promotion of these medicines.

Having individual states impose distinct labeling rules would create confusion around critical health details printed on packaging.

CHPA strives to continually reinforce, define, and quantify the value of consumer healthcare products for consumers and the healthcare system. These CHPA research initiatives and products highlight the meaningful ways that consumer healthcare products provide consumers access to trusted, affordable, empowering self-care options.

The advertising of nonprescription, over-the-counter medicines helps acquaint the public with these products and must be truthful, not misleading, and must meet high standards reflecting the nature of the product advertised.

This white paper provides guidance for the evaluation and reporting of impurities in OTC monograph drug products formulated as topicals and topical rinses. This document serves as CHPA's member company consensus on this complex issue.

Find frequently asked questions about OTC oral pain relievers and fever reducers including acetaminophen, aspirin, ibuprofen, ketoprofen, and naproxen sodium.

Filter Results